| Regulation | LIS Non-Compliance Area | Correction Required | Plans of Correction | Correction Date | POC Status |
| 6400.16 | Individual #1 is prescribed Novolog 10 units a day to be administered before breakfast, lunch, and dinner. They were to be administered additional units of Novolog based on their sliding scale. From September 2025 to midway through December 2025, Individual #1 did not receive the correct dosage of Novolog. They consistently received less Novolog than they were prescribed. | Abuse of an individual is prohibited. Abuse is an act or omission of an act that willfully deprives an individual of rights or human dignity or which may cause or causes actual physical injury or emotional harm to an individual, such as striking or kicking an individual; neglect; rape; sexual molestation, sexual exploitation or sexual harassment of an individual; sexual contact between a staff person and an individual; restraining an individual without following the requirements in this chapter; financial exploitation of an individual; humiliating an individual; or withholding regularly scheduled meals. | Medication Error IM report #9780815 and IM report of Neglect #9780780 were filed on 2/04/2026. The Health Promotion was updated to reference the current prescribed sliding scale order by the newly assigned Residential Program Specialist and staff of the home were trained on updates on 2/04/2026 to ensure all staff were administering the correct dose of Novolog, see Attachments #4 & #5 Individual #1 had an Endocrinology appointment on 2/6/2026, at this appointment the newly assigned Residential Program Specialist requested clarification on questions that were discussed during the licensing inspection. A copy of the appointment notes were obtained, see Attachment #6. Based on clarifications the Health Promotions were updated and staff were all trained, see Attachment #7. The violation was reviewed with the Residential Coordinator and they were trained on Regulation 6400.16 by the Director of Quality Assurance on 2/18/2026, see Attachment #8. |
02/18/2026
| Implemented |
| 6400.141(c)(6) | Individual #1 had a TB test on 7/24/24. No results were documented. | The physical examination shall include: Tuberculin skin testing by Mantoux method with negative results every 2 years for individuals 1 year of age or older; or, if tuberculin skin test is positive, an initial chest x-ray with results noted. | Individual #1 was scheduled for a TB screening on 2/12/2026, results of TB screening will be sent as Attachment #9. The results of the TB screening will be sent as Attachment #10 once completed. The violation was reviewed with the newly assigned Residential Program Specialist and Residential Coordinator were trained on Regulation 6400.141(c)(6) by Director of Quality Assurance on 2/18/2026, see Attachment #11. The newly assigned Residential Program Specialist and Residential Coordinator were trained on ODP Announcement 24-094 by Director of Quality Assurance by Director of Quality Assurance on 2/18/2026, see Attachment #12. |
02/18/2026
| Implemented |
| 6400.141(c)(13) | The allergies documented on Individual #1's most recent physical completed 9/18/25 do not match Individual #1's ISP. The physical documents that Individual #1 is allergic to Clindamycin. This allergy is not documented in the ISP. | The physical examination shall include: Allergies or contraindicated medications. | Residential Program Specialist sent an email to the Supports Coordinator on 2/13/2026 requesting to update the ISP with all allergies, see Attachment #14. The ISP was updated by the Supports Coordinator, see Attachment #15. The violation was reviewed with the newly assigned Residential Program Specialist and Residential Coordinator and they were trained on Regulation 6400.141(c)(13) by Director of Quality Assurance on 2/18/2026, see Attachment #16. |
02/18/2026
| Implemented |
| 6400.144 | Individual #1 is prescribed Artificial Tears as a PRN. At the time of the inspection, this medication was not available at the home. | Health services, such as medical, nursing, pharmaceutical, dental, dietary and psychological services that are planned or prescribed for the individual shall be arranged for or provided.
| Individual #1's PRN for artificial tears was listed on the MAR from their other provider when they transitioned to CCCC. The Residential Coordinator verified with the PCP that eye drops were not prescribed on 2/5/2026 and the order was faxed to CCCC on 2/10/2026, see Attachment #18. The QC Artificial Tears Drops were Discontinued on the MAR on 2/10/2026, see Attachment #19. Information was provided to the pharmacy. The violation was reviewed with the newly assigned Residential Program Specialist and Residential Coordinator, and they were trained on Regulation 6400.144 by Director of Quality Assurance on 2/18/2026, see Attachment #20. |
02/18/2026
| Implemented |
| 6400.166(a)(2) | Individual #1's MARs from September 2025 to the present do not include the prescriber for each medication. | A medication record shall be kept, including the following for each individual for whom a prescription medication is administered: Name of the prescriber. | Prescribers were added to all medications on the February 2026 MARs, see Attachment #21. The violation was reviewed with the Residential Coordinator and they were trained on Regulation 6400.166(a)(2) by Director of Quality Assurance on 2/18/2026, see Attachment #22. All staff in the home will be trained on how to document prescribers on the MARs by a Medication Administration Trainer no later than 3/31/2026, and will be sent as Attachment #23. |
03/31/2026
| Implemented |
| 6400.167(a)(1) | Individual #1 did not receive their 2mg of Perphenazine on 12/19/25 at 8pm. | Medication errors include the following: Failure to administer a medication. | Medication Error IM report #9781193 was file on 2/05/2026. A debriefing was completed on 2/5/2026 with the target following the agency Policy and Procedures for Medication Administration, see Attachment #24. The violation was reviewed with the Residential Coordinator and they were trained on Regulation 6400.167(a)(1) by Director of Quality Assurance on 2/18/2026, see Attachment #25. |
02/24/2026
| Implemented |